Neurology
Motor Neurone Disease: Investigating if specific toxins contribute towards to the onset of MND
Research Objectives
Status
Completed
Recruitment
Closed
Study location
Wesley Research Institute, The University of Queensland
Study type
Investigator Initiated
Lead investigator
- Prof Pamela McCombe (UQ)
Experienced investigator
- Dr Aven Lee (UQ)
About this research project
Motor neurone disease (MND) is a severe disease for which there is no successful therapy. Currently there is no cure for MND. The best approach in clinical practice is primary prevention through the modification of risk factors.
In a novel study previously funded by Wesley Research Institute, we have demonstrated that MND patients have increased levels of homocysteine sulfinic acid, an excitotoxin that can be produced by the gut microbiota.
In this follow up study, we will investigate if the increases in these excitotoxins change during disease progression and correlate with survival. These toxins could contribute to the onset of MND. It’s possible that eliminating these gut toxins could lead to better patient outcomes.
Latest News
New Study Reveals Hidden Immune Activity in Cardiac Sarcoidosis Using Spatial Biology
A new study led by researchers at Wesley Research Institute, published in the European Heart Journal—one of the world’s most widely read cardiology journals—marks a significant advance in cardiac sarcoidosis (CS) research.
New Research Program Transforming Cardiovascular Care
A new research program at Wesley Research Institute, led by Associate Professor Eliot Peyster, is bringing unique human tissue models, advanced spatial biology analyses, and implementation-focused computational and ‘AI’ tools into cardiovascular research.
Where Math Meets Medicine: Cooper’s Role in Transforming Cancer Care
For Cooper, the future of cancer research lies at the intersection of numbers and biology. We caught up with Cooper, to learn how he’s diving into one of the most exciting and challenging areas of modern science: computational biology.